Title of article
Allergic contact dermatitis to latanoprost
Author/Authors
Kelly Michele Jerstad، نويسنده , , Erin Warshaw، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2002
Pages
3
From page
39
To page
41
Abstract
An 85-year-old male with glaucoma presented with a 1-[frac12] year history of tearing; red eyes; and pruritic, edematous, eczematous eyelids. Treatment for presumed ocular rosacea and seborrhea was unhelpful. Patch testing to our standard 64 antigens yielded a positive reaction to Balsam of Peru. Notably, benzalkonium chloride, thimerosal, and other preservatives elicited negative reactions. Repeat open application testing elicited positive results to Xalatan (latanoprost) 0.005% ophthalmic solution (Pharmacia [amp ] Upjohn, Kalamazoo, MI). A second session of patch tests to 10 personal products, in addition to Xalatan 0.005% solution and the Xalatan vehicle (provided by the manufacturer), elicited a strong positive reaction only to the full preparation of Xalatan 0.005% solution. This report describes the first known case of ACD to latanoprost, a new prostaglandin analog that is widely prescribed for treatment of glaucoma.
Journal title
Dermatitis
Serial Year
2002
Journal title
Dermatitis
Record number
461307
Link To Document